Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanthanum Carbonate in Stage 3 CKD
NCT01128179Phase 2Completed
- Sponsor
- Takeda
- Start
- Dec 2010
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic kidney disease (CKD) comparing Lanthanum carbonate with Placebo (2 arms). Primary endpoint: Natural Logarithm Transformed Serum Intact Fibroblast Growth Factor 23 at 12 weeks. Started Dec 2010; status: completed.
02
Drugs
lanthanum carbonate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01128179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01128179.